Description
Mollugin, which can be extracted from the roots of Rubia cordifolia L, could be a novel therapeutic candidate for bone loss-associated disorders including osteoporosis, rheumatoid arthritis, and periodontitis. It is a novel modulator of the HER2 pathway in HER2-overexpressing cancer cells with a potential role in the treatment and prevention of human breast and ovarian cancer with HER2 overexpression. Besides, Mollugin may be a JAK2 inhibitor and inhibits LPS-induced inflammatory responses by blocking the activation of the JAK-STAT pathway.
Synonyms
Rubimaillin; 2H-Naphtho[1,2-b]pyran-5-carboxylic acid; 6-hydroxy-2, 2-dimethyl-, methylester; 2,2-Dimethyl-6-hydroxy-2H-naphtho[1,2-b]pyran-5-carboxylic acid methyl ester; 6-Hydroxy-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5-carboxylic acid methyl ester; Methyl 6-hydroxy-2,2-dimethylbenzo[h]chromene-5-carboxylate; MOLLUGIN(SH)
Molecular Formula
C17H16O4
Boiling Point
453.2±45.0 °C(Predicted)
Density
1.239±0.06 g/cm3(Predicted)
Solubility
Chloroform (Slightly), Ethyl Acetate (Slightly)
Uses
Mollugin is an anti-tumor agent inducing apoptosis and autophagy in various cancer models.